Browsing School of Medicine by Subject "CHEK2"
Now showing items 1-1 of 1
-
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer
(2012)Purpose: A germline microRNA binding site-disrupting variant, the KRAS-variant (rs61764370), is associated with an increased risk of developing several cancers. Because this variant is most strongly associated with ovarian ...